Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma
- 7 July 2008
- journal article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 13 (3) , 191-197
- https://doi.org/10.1111/j.1442-2050.2000.00110.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: Do histological assessment and p53 overexpression predict chemo-responsiveness?European Journal Of Cancer, 1997
- Structure and Function of the p53 Tumor Suppressor Gene: Clues for Rational Cancer Therapeutic StrategiesJNCI Journal of the National Cancer Institute, 1996
- bcl-2: Role in epithelial differentiation and oncogenesisHuman Pathology, 1996
- Prognostic value of histopathologic parameters of esophageal squamous cell carcinomaCancer, 1995
- Surgery, radiotherapy, and chemotherapy for esophageal cancerCurrent Opinion in Gastroenterology, 1995
- Cancer of the esophagusCurrent Opinion in Gastroenterology, 1995
- Histopathological evaluation of response to pre-operative concurrent chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagusDiseases of the Esophagus, 1995
- Molecular mechanisms of drug resistance in tumoursThe Journal of Pathology, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer, 1994